Ophthalmology Times
CONTINUE TO SITE >

OR WAIT 15 SECS

Ophthalmology Times
Spotlight
Clinical
News
Media
Business
Conferences
Publications
Resources
Subscribe

  • Advertise
  • Contact Us
  • Editorial
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2021 MJH Life Sciences and Ophthalmology Times. All rights reserved.

Spotlight
  • Cataract Therapeutics
  • Glaucoma Insights
  • Branded vs Generics
  • CME Activities
  • Glaucoma Management
  • Dry Eye Viewpoint
  • Diabetic Eye Disease Viewpoints
ClinicalSee All >
  • Cataract
  • Clinical Diagnosis
  • Cornea
  • Glaucoma
  • IOL
  • OCT
  • Ocular Allergy
  • Ocular Surface Disease
  • Pediatrics
  • Refractive
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
  • Understanding Antibiotic Resistance
  • Advertise
  • Contact Us
  • Editorial
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.

Advancements in dry eye management

Introduction and overview of dry eye

Epidemiology and consequences of untreated dry eye

Diagnosis and overlooking asymptomatic patients with dry eye

Standard testing and assessment for dry eye disease

General principles of treatment of dry eye disease

Communication between ODs and MDs for optimal care

Review of artificial tears for dry eye

Corticosteroids and Immunomodulators for the treatment of dry eye

The role of nutritional supplements and antibiotics in dry eye

Treating meibomian gland dysfunction

In-office procedures and patient resistance for dry eye treatments

Treatment methods for aqueous dry eye

Challenges in the management of dry eye

Counseling and formulary concerns for dry eye therapies

Overlapping diseases and the impact of COVID-19

Agents in the pipeline for dry eye disease

Novel agents in the pipeline for dry eye disease